Viking Therapeutics prices USD 225 million convertible senior notes offering
Bitget2026/09/24 11:05- Viking Therapeutics priced an upsized USD 225 million offering of 2.00% convertible senior notes due 2032.
- Settlement is scheduled for Sept. 25, subject to customary closing conditions.
- Underwriters hold a 30-day option to buy up to an additional USD 33.75 million principal amount to cover over-allotments.
- Notes convert at an initial 19.7044 shares per USD 1,000, implying an initial conversion price of about USD 50.75.
- Net proceeds are estimated at about USD 218 million, earmarked mainly for VK2735 and VK3019 development.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Lithium-For-Earth Raises KRW 1.32 Billion in Private Placement
Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion
Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.
Subaru Publishes Transcript of First-Half FYE 2027 Financial Results Presentation
Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output
Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.
Crypto prices
More
